Growth Metrics

Oscar Health (OSCR) Capital Expenditures (2020 - 2025)

Oscar Health's Capital Expenditures history spans 6 years, with the latest figure at $9.1 million for Q4 2025.

  • For Q4 2025, Capital Expenditures rose 32.89% year-over-year to $9.1 million; the TTM value through Dec 2025 reached $36.4 million, up 30.38%, while the annual FY2025 figure was $36.4 million, 30.38% up from the prior year.
  • Capital Expenditures reached $9.1 million in Q4 2025 per OSCR's latest filing, up from $9.0 million in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $9.6 million in Q3 2022 to a low of $5.6 million in Q2 2023.
  • Average Capital Expenditures over 5 years is $7.2 million, with a median of $7.0 million recorded in 2022.
  • Peak YoY movement for Capital Expenditures: soared 117.24% in 2021, then plummeted 32.63% in 2023.
  • A 5-year view of Capital Expenditures shows it stood at $7.2 million in 2021, then dropped by 1.05% to $7.1 million in 2022, then decreased by 14.42% to $6.1 million in 2023, then grew by 11.75% to $6.8 million in 2024, then soared by 32.89% to $9.1 million in 2025.
  • Per Business Quant, the three most recent readings for OSCR's Capital Expenditures are $9.1 million (Q4 2025), $9.0 million (Q3 2025), and $9.3 million (Q2 2025).